Logo

Akoya Biosciences: Niro Ramachandran, Gavin Gordon

Sep 02, 2020

Akoya Biosciences has appointed Niro Ramachandran as its chief business officer and Gavin Gordon as VP of clinical market development.

Ramachandran previously served as VP of NanoString's spatial biology business unit. Prior to NanoString, he held the role of R&D manager at Life Technologies (now part of Thermo Fisher Scientific). In addition, he cofounded and served as chief technology officer of Auguron.

Prior to Akoya, Gordon held senior level positions at Fluidigm and Thermo Fisher Scientific. He has also served as assistant professor at Harvard Medical School and as a faculty member of Brigham and Women's Hospital and Dana-Farber/Harvard Cancer Center.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.